MA33368B1 - Préparation de chlorhydrate de nalmefene à partir de naltrexone - Google Patents

Préparation de chlorhydrate de nalmefene à partir de naltrexone

Info

Publication number
MA33368B1
MA33368B1 MA34465A MA34465A MA33368B1 MA 33368 B1 MA33368 B1 MA 33368B1 MA 34465 A MA34465 A MA 34465A MA 34465 A MA34465 A MA 34465A MA 33368 B1 MA33368 B1 MA 33368B1
Authority
MA
Morocco
Prior art keywords
naltrexone
nalmefene hydrochloride
preparation
producing
hydrochloride
Prior art date
Application number
MA34465A
Other languages
English (en)
French (fr)
Inventor
Faveri Carla De
Mauro Casarin
Michele Brusegan
Original Assignee
Lundbeck & Co As H
Abu Ghazaleh Intellectual Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43222172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33368(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H, Abu Ghazaleh Intellectual Prop filed Critical Lundbeck & Co As H
Publication of MA33368B1 publication Critical patent/MA33368B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
MA34465A 2009-05-25 2010-05-21 Préparation de chlorhydrate de nalmefene à partir de naltrexone MA33368B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200900650 2009-05-25
US18102209P 2009-05-26 2009-05-26
PCT/DK2010/050110 WO2010136039A1 (en) 2009-05-25 2010-05-21 Preparation of nalmefene hydrochloride from naltrexone

Publications (1)

Publication Number Publication Date
MA33368B1 true MA33368B1 (fr) 2012-06-01

Family

ID=43222172

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34465A MA33368B1 (fr) 2009-05-25 2010-05-21 Préparation de chlorhydrate de nalmefene à partir de naltrexone

Country Status (35)

Country Link
US (1) US8598352B2 (enExample)
EP (1) EP2435439B8 (enExample)
JP (1) JP5794980B2 (enExample)
KR (1) KR101716522B1 (enExample)
CN (1) CN102459276B (enExample)
AR (1) AR076891A1 (enExample)
AU (1) AU2010252392B2 (enExample)
BR (1) BRPI1010975B1 (enExample)
CA (1) CA2763093C (enExample)
CL (1) CL2011002974A1 (enExample)
CO (1) CO6470832A2 (enExample)
CR (1) CR20110612A (enExample)
DK (1) DK2435439T3 (enExample)
DO (1) DOP2011000362A (enExample)
EA (1) EA019331B1 (enExample)
ES (1) ES2564006T3 (enExample)
GE (1) GEP20146190B (enExample)
HR (1) HRP20160110T1 (enExample)
HU (1) HUE026892T2 (enExample)
IL (1) IL216422A (enExample)
MA (1) MA33368B1 (enExample)
ME (1) ME02622B (enExample)
MX (1) MX2011012502A (enExample)
MY (1) MY158251A (enExample)
NZ (1) NZ596988A (enExample)
PL (1) PL2435439T3 (enExample)
RS (1) RS54599B1 (enExample)
SG (1) SG176205A1 (enExample)
SI (1) SI2435439T1 (enExample)
SM (1) SMT201600061B (enExample)
TN (1) TN2011000590A1 (enExample)
TW (1) TWI469985B (enExample)
UA (1) UA106752C2 (enExample)
WO (1) WO2010136039A1 (enExample)
ZA (1) ZA201108659B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2802295C (en) 2010-06-11 2016-09-20 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
HRP20170379T1 (hr) 2010-11-05 2017-05-05 H. Lundbeck A/S Postupak proizvodnje naltreksona
CN103012416B (zh) * 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
TWI560170B (en) * 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
CN102584840A (zh) * 2011-12-28 2012-07-18 南京优科生物医药有限公司 一种制备纳美芬化合物的方法
WO2013164383A1 (en) 2012-05-03 2013-11-07 H. Lundbeck A/S Method for the manufacturing of naltrexone
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
CN103204859B (zh) * 2013-04-25 2015-12-02 四川海思科制药有限公司 一种盐酸纳美芬化合物及其制备方法
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
JP6448645B2 (ja) 2013-12-20 2019-01-09 ハー・ルンドベック・アクチエゼルスカベット メランコリアの特徴を伴う抑うつ障害を処置するための、カッパ−活性を伴うオピオイド受容体拮抗薬およびボルチオキセチンの使用
SG10201809280PA (en) 2014-04-22 2018-11-29 Otsuka Pharma Co Ltd Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
CN104513251A (zh) * 2014-11-28 2015-04-15 安徽悦康凯悦制药有限公司 一种盐酸纳美芬的制备方法
US9757372B2 (en) * 2015-03-25 2017-09-12 Taiwanj Pharmaceuticals Co., Ltd. Toll-like receptor 4 antagonists and use in autoimmune liver diseases
RU2712232C1 (ru) * 2018-10-05 2020-01-27 Федеральное государственное унитарное предприятие "Научно-исследовательский институт гигиены, профпатологии и экологии человека" Федерального медико-биологического агентства Улучшенный способ получения налмефена из налтрексона
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
CA3196369A1 (en) 2020-11-02 2022-05-05 C. Frederick M. Huntley Process for purifying noroxymorphone
US20240109907A1 (en) 2021-01-28 2024-04-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117843650A (zh) * 2023-12-27 2024-04-09 南京海纳医药科技股份有限公司 一种盐酸纳美芬的精制方法
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) * 2024-08-19 2024-12-06 南京海鲸药业股份有限公司 一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341764A (en) 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor
US4322426A (en) 1980-04-28 1982-03-30 E. I. Du Pont De Nemours And Company 17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
US4535157A (en) * 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) * 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
US7687646B2 (en) 2006-03-28 2010-03-30 Azad Pharmaceutical Ingredients, Ag Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
GB2447013A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Analgesic composition containing buprenorphone and nalmefene

Also Published As

Publication number Publication date
SMT201600061B (it) 2016-07-01
CA2763093C (en) 2017-03-07
BRPI1010975B1 (pt) 2021-08-24
KR101716522B1 (ko) 2017-03-14
TWI469985B (zh) 2015-01-21
MX2011012502A (es) 2011-12-12
UA106752C2 (uk) 2014-10-10
GEP20146190B (en) 2014-11-10
AR076891A1 (es) 2011-07-13
DOP2011000362A (es) 2012-07-15
HUE026892T2 (en) 2016-07-28
JP2012527489A (ja) 2012-11-08
PL2435439T3 (pl) 2016-05-31
TW201043634A (en) 2010-12-16
CO6470832A2 (es) 2012-06-29
IL216422A (en) 2015-06-30
IL216422A0 (en) 2012-02-29
HRP20160110T1 (hr) 2016-03-11
ME02622B (me) 2017-06-20
BRPI1010975A2 (pt) 2015-10-20
EP2435439B8 (en) 2016-05-18
EP2435439A1 (en) 2012-04-04
EA201171461A1 (ru) 2012-05-30
MY158251A (en) 2016-09-30
SG176205A1 (en) 2011-12-29
US8598352B2 (en) 2013-12-03
AU2010252392B2 (en) 2014-10-23
CA2763093A1 (en) 2010-12-02
CN102459276A (zh) 2012-05-16
AU2010252392A1 (en) 2012-01-12
ES2564006T3 (es) 2016-03-17
JP5794980B2 (ja) 2015-10-14
NZ596988A (en) 2013-03-28
KR20120023704A (ko) 2012-03-13
EA019331B1 (ru) 2014-02-28
RS54599B1 (sr) 2016-08-31
CR20110612A (es) 2012-02-22
CL2011002974A1 (es) 2012-04-13
DK2435439T3 (en) 2016-02-29
ZA201108659B (en) 2013-02-27
WO2010136039A1 (en) 2010-12-02
EP2435439B1 (en) 2016-01-06
TN2011000590A1 (en) 2013-05-24
US20120123123A1 (en) 2012-05-17
CN102459276B (zh) 2016-09-21
SI2435439T1 (sl) 2016-06-30

Similar Documents

Publication Publication Date Title
MA33368B1 (fr) Préparation de chlorhydrate de nalmefene à partir de naltrexone
EP2330224A4 (en) HIGH-PURITY COPPER AND METHOD FOR THE ELECTROLYTIC MANUFACTURE OF HIGH-CLEAN COPPER
EP2441831A4 (en) PROCESS FOR PRODUCING A PROTEIN
EP2326443A4 (en) PROCESS FOR PRODUCING OBJECTS WITH NANOMETALLIC OR COMPOSITE METAL
EP2213180A4 (en) METHOD FOR PRODUCING A CARBONATED BEVERAGE
MY173940A (en) Process for producing pyrrole compound
EP2423312A4 (en) METHOD FOR PRODUCING A CHRYSANTHEMAN PLANT WITH DELPHINIDINE-CONTAINING BLOOMS
EP2336346A4 (en) PROCESS FOR THE PREPARATION OF ACRYLAMIDE
EP2584055A4 (en) PROCESS FOR REMOVING COPPERIONS FROM A COPPER-BASED NICKEL CHLORIDE SOLUTION AND METHOD FOR PRODUCING AN ELECTROLYTIC NICKEL
MA32255B1 (fr) Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures
EP2502508A4 (en) METHOD FOR PRODUCING A CARBONATED BEVERAGE
EP2179995A4 (en) METHOD FOR THE PRODUCTION OF PURIFIED AMMONIUM SALT FROM FLUORINATED BIS-SULFONYLIMIDE
MX2012005760A (es) Metodo para la eliminacion de cloruro en solucion de sulfato de cinc.
EP2098480A4 (en) PROCESS FOR THE PREPARATION OF IODPENTAFLUORIDE
EA200700906A1 (ru) Низкотемпературный промышленный процесс
EP2138514A4 (en) PROCESS FOR PREPARING STARCH WITH A HIGH CONSTITUTION OF HARD DIGESTIVE STRENGTH
EP2006274A4 (en) Method for producing 3,3,3-trifluoropropionic acid chloride
EP1894885A4 (en) REACTOR FOR THE MANUFACTURE OF CHLORINE AND METHOD FOR THE PRODUCTION OF CHLORINE
EP2325162A4 (en) Process for producing xylylenediamine
EP2692877A4 (en) COPPER ALLOY AND MANUFACTURING METHOD FOR COPPER ALLOY
EP2554247A4 (en) ERROR-FREE HYDROGEN CUTTING MEMBRANE, PRODUCTION PROCESS FOR THE NON-FAILED WATER-SECTION MEMBRANE AND HYDROGEN-CROPPING METHOD
EP2096103A4 (en) PROCESS FOR PREPARING A BETAIN
EP2474995A4 (en) MANUFACTURING PROCESS FOR A SOI WAFER
EP2452918A4 (en) PROCESS FOR PRODUCING HYDROGEN HYDROGEN
EP1930006A4 (en) METHOD FOR PRODUCING A CHINOLONE-CONTAINING LYOPHILIZED PREPARATION